A Northwestern University team reports in Science Translational Medicine (published April 23, 2025) that piperacillin, a penicillin-class drug, cured Lyme infection in mice at 100× lower doses than doxycycline, the current standard.
That matters because doxycycline can disrupt the microbiome and still doesn’t help an estimated 10–20% of people and it isn’t approved for young children, who face high tick exposure.
The clarity comes from mechanism: piperacillin appears to target Borrelia’s distinct cell wall synthesis pattern, blocking growth and division with unusual specificity.
The hopeful implication isn’t a guaranteed human replacement yet, but a glimpse of more custom, microbiome-sparing Lyme treatment and even the possibility of a single-dose preventive shot after a known deer tick bite.
If future Lyme care can be tailored to the biology of a specific bacterium rather than carpet-bombing the microbiome how might that reshape what we consider “effective” treatment in infectious disease?
Not used in humans yet, but there is hope!
Posted by Phoiph (Member # 41238) on :
Thanks for posting on piperacillin again, Hiker.
This discovery seems very promising, and I truly hope it continues to be pursued for Lyme. There don't seem to be any updates as of yet:
If they hadn't spent so much time spinning the narrative that "Lyme is hard to catch and easy to cure. No such thing as chronic Lyme."
We could have been using this drug. It is an older drug. Piperacillin is considered a well-established, or "older" antibiotic, having been patented in 1974 and approved for medical use in 1981. That means I would have only had Lyme for a decade at that point. (Yes, I am that old)
I think of all of the people who developed C.diff from using harmful to the gut antibiotics.
This gives some hope. Thanks for posting, Hiker!
Posted by Phoiph (Member # 41238) on :
Kgg,
Exactly.
Since piperacillin already has a proven safety profile, why isn't it already being used "off label" on willing participants who can't tolerate traditional antibiotics, or in cases when antibiotics have failed?
So many other higher risk drugs are used for Lyme in this way.
I would think LLMD's would be all over this already, but I can't find any updates.
So frustrating and disappointing how long-suffering Lyme patients are still being sidelined and strung along.
Posted by kgg (Member # 5867) on :
Phoiph, I think that is the value of social media. It has many flaws, but getting the word out about this antibiotic is important.
If LLMDs don't start using it, people with Lyme need to start demanding it.
I confess, I am skeptical of "LLMDs" since my son flunked out of their treatment. If they don't use it and people stay sick, then they still are making $$.
Posted by Phoiph (Member # 41238) on :
kgg,
Your son is not alone! I was also a serial LLMD flunkie. I was deemed a treatment failure every time.
Once I became well on my own with mHBOT, I wrote them all cordial letters explaining the exact method I used in hopes it would help their patients. (I received no replies.)